Amundi
PCVX icon

Amundi’s Vaxcyte PCVX Stock Holding History

Amundi’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$569K Hold
10,003
– – ﹤0.01% 1611
2026
Q2 		$581K Sell
10,003
-2,955
-23% -$160K ﹤0.01% 1592
2026
Q1 		$753K Buy
12,958
+7,868
+155% +$427K ﹤0.01% 1383
2025
Q4 		$235K Buy
+5,090
New +$228K ﹤0.01% 1718
2025
Q2 		– Sell
-343,512
Closed -$10.5M – 2040
2025
Q1 		$10.5M Sell
343,512
-63,416
-16% -$5.07M ﹤0.01% 821
2024
Q4 		$33M Sell
406,928
-27,864
-6% -$2.77M 0.01% 639
2024
Q3 		$48.6M Sell
434,792
-7,516
-2% -$677K 0.02% 551
2024
Q2 		$33.7M Buy
442,308
+139,951
+46% +$9.5M 0.01% 610
2024
Q1 		$18.3M Sell
302,357
-27,431
-8% -$1.9M 0.01% 715
2023
Q4 		$20M Sell
329,788
-13,124
-4% -$682K 0.01% 717
2023
Q3 		$15.8M Buy
342,912
+80,311
+31% +$3.96M 0.01% 746
2023
Q2 		$12.9M Buy
+262,601
New +$12.4M 0.01% 790
2022
Q4 		– Sell
-2,604
Closed -$62K – 1957
2022
Q3 		$62K Hold
2,604
– – ﹤0.01% 1634
2022
Q2 		$64K Buy
+2,604
New +$60.3K ﹤0.01% 1517
2022
Q1 		– Sell
-5,795
Closed -$115K – 1704
2021
Q4 		$115K Buy
+5,795
New +$135K ﹤0.01% 1557

Other funds holding PCVX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
C WorldWide Group
C WorldWide Group Copenhagen, Denmark $3.96B AUM 10.41% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Amundi's PCVX Position: Q3 2026 in Review

Amundi held its Vaxcyte (PCVX) position steady in Q3 2026 at 10,003 shares worth $569K. The position accounts for ﹤0.01% of the portfolio, ranked #1611.

Amundi first reported a position in PCVX in Q4 2021 and has held it in 15 quarters since. The position peaked at $48.6M in Q3 2024. 139 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.

  • Amundi held 10,003 shares of Vaxcyte worth $569K as of Q3 2026.
  • Amundi left its Vaxcyte share count unchanged in Q3 2026.
  • Vaxcyte made up ﹤0.01% of Amundi's portfolio in Q3 2026, its #1611 holding.
  • Amundi first reported a position in Vaxcyte in Q4 2021 and has held it in 15 quarters since.
  • Amundi's Vaxcyte position peaked at $48.6M in Q3 2024.
  • 139 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.

Based on Amundi's 13F filing for Q3 2026, filed 6 Nov 2026.